Table 3 |
||
|
Additional amino acid substitutions identified by ERG11 sequencing in five C. albicans isolates with reduced susceptibility to fluconazole. |
||
|
Patient/isolate no. |
Substitutions detected by RCA |
Substitutions detected by DNA sequencing |
|
|
||
|
5 |
G307S |
G307S, G450V |
|
6-Aa |
E266D |
E266D, D153E |
|
6-Ba |
D116E |
D116E, D153E |
|
10 |
E266D, V488I, S405F, Y132H |
E266D, V488I, S405F, Y132H, K108E |
|
11 |
E266D, V437I |
E266D, V437I, F126L |
|
|
||
|
12-Aa |
G464S |
G464S, K108E |
|
|
||
|
a The "A" and "B" notation of patient numbers refers to isolates which were cultured sequentially from the same patient at different times. |
||
|
Wang et al. BMC Microbiology 2009 9:167 doi:10.1186/1471-2180-9-167 |
||